Your cart

Your cart is empty

The 2026 Hemp Crackdown: What H.R. 5371 Means for Mushroom Gummies

A lot of people are watching the hemp industry right now with real concern. H.R. 5371 passed in late 2025, and enforcement kicks in November 12, 2026. If you buy delta-8 gummies, THCa, or other hemp-derived products, your options are about to shrink fast. Many brands you know will either reformulate or disappear from shelves.

Wunder isn't one of them. Here's why, and what the law actually says.

What H.R. 5371 actually says

H.R. 5371, sometimes called the Farm Bill 2025 amendment, closes the loophole that let hemp processors sell psychoactive cannabinoids legally by keeping total delta-9 THC below 0.3% by dry weight. The bill bans hemp-derived intoxicants above that 0.3% threshold, regardless of which cannabinoid delivers the effect.

That means delta-8 THC, delta-10 THC, THCa (measured after decarboxylation), and related psychoactive hemp-derived compounds are now explicitly prohibited under federal law. The 0.3% delta-9 exemption no longer applies to converted or synthetically derived cannabinoids.

Enforcement date: November 12, 2026. After that, manufacturers, distributors, and retailers selling these compounds face federal penalties under the Controlled Substances Act.

This is not a rumor or a gray area. The bill passed. The clock is running.

What products are affected

Any product containing hemp-derived cannabinoids that produce intoxication falls under this rule. The clearest examples:

  • Delta-8 THC: derived from hemp CBD via chemical conversion, and the primary target of the bill
  • Delta-10 THC: same conversion process, different compound
  • THCa: technically below the delta-9 limit in raw form, but converts to delta-9 when heated; the bill accounts for this
  • Any other hemp-derived compound with psychoactive effects above 0.3% THC equivalent

Brands that built their product lines around these compounds face hard choices: reformulate, find a new supply chain, or exit the category entirely by November.

What is NOT affected by H.R. 5371

The bill targets hemp-derived cannabinoids. Full stop. It says nothing about botanical compounds from different plants entirely.

These are not affected:

  • Kava (from the Piper methysticum plant): not hemp, not a cannabinoid, not covered
  • Blue lotus (Nymphaea caerulea): an aquatic plant used in traditional wellness contexts
  • Kanna (Sceletium tortuosum): a South African succulent
  • Functional mushroom blends (lion's mane, reishi, cordyceps, and similar)

None of these are hemp. None are cannabinoids. H.R. 5371 has no authority over them. Their legal status comes from entirely different regulatory frameworks, and nothing in this bill changes that.

What's in Wunder instead

Wunder's gummies don't contain delta-8, delta-10, THCa, or any psychoactive hemp-derived cannabinoid.

Wunder used to make Amanita gummies. We don't anymore, and nothing we sell today contains Amanita. Wunder's gummies are built on our proprietary blend, and some flavors add one botanical: kava, blue lotus or kanna. No hemp-derived cannabinoid appears in the product at any concentration.

Curious about amanita muscaria? Our Amanita muscaria gummies explainer covers what it is and what the FDA said about it. For kava and blue lotus, the blue lotus guide goes deeper on how those compounds work.

What to do if your current brand disappears from shelves

If you've been buying delta-8 or similar gummies, November 2026 is a real deadline to find alternatives. Some brands will reformulate. Many won't survive the transition.

Three things to watch for as you look around:

Read the ingredient list, not the marketing copy. A product that switched from delta-8 to "hemp extract" without specifying what that means is probably still a cannabinoid product. Look for specific named ingredients like kava, blue lotus or kanna. Vague "botanical blend" language with no milligram breakdown deserves scrutiny.

Third-party testing still matters. Any reputable botanical product should have a COA from an independent lab. For kava, look for the kavalactone percentage.

The effects are different from what you're used to. Kava and blue lotus don't produce a cannabis-like high. They produce something closer to a calming, mood-lifting effect. The experience is distinct from both cannabis and classical psychedelics, and knowing what you're getting into helps you dose correctly.

Want to try Wunder's formula? The high-potency gummy lineup has COAs available for every product, clearly labeled ingredients, and zero hemp-derived cannabinoids.

Frequently asked questions

Are mushroom gummies affected by the 2026 hemp law?

H.R. 5371 targets hemp-derived cannabinoids like delta-8, THCa, and others. Gummies made from functional mushroom blends or botanicals like kava don't contain hemp-derived cannabinoids, which is what the bill goes after.

What does H.R. 5371 ban exactly?

Hemp-derived intoxicants above 0.3% THC equivalent, including delta-8 THC, delta-10 THC, and THCa (after decarboxylation). Enforcement begins November 12, 2026.

Is kava legal in 2026?

Kava is not a hemp-derived cannabinoid and is not regulated under H.R. 5371 or any federal controlled substance scheduling. It's sold as a dietary supplement in most US states.

Will delta-8 gummies still be available after November 2026?

Under federal law, no. After November 12, 2026, delta-8 and similar hemp-derived intoxicants will be prohibited. Federal enforcement will make most distribution channels non-viable.

What makes Wunder's gummies different from delta-8 products?

The active ingredients are entirely different. Delta-8 products work via THC-receptor binding (CB1). Wunder's formula uses kava (GABA-A modulation), blue lotus, and kanna (serotonin reuptake inhibition). Different mechanism, different effect profile.

About the author

Sage Mercer writes about entheogenic plants, harm reduction, and mushroom-adjacent botanicals. When not writing, Sage is usually somewhere in the woods.

Previous post
Next post